Propagation and characterisation of dendritic cells from G-CSF mobilised peripheral blood monocytes and stem cells in common marmoset monkeys

Journal of Immunological Methods
Shilpanjali PrasadPatrick Toby H Coates

Abstract

The common marmoset is a small New World Primate that has been used as an immunological model for a number of human diseases. Dendritic cells (DC) have not been extensively characterised in this species and in particular protocols to derive DC from living donors without the need for animal sacrifice are presently lacking. This study establishes new protocols to generate substantial numbers of marmoset DC for use in cell therapy studies. Recombinant human G-CSF was used to mobilise peripheral blood monocytes and CD34(+) stem cells in sufficient numbers for large scale in-vitro DC propagation using cytokine conditioning including IL-4, GM-CSF, FLT3-L, stem cell factor and thrombopoietin. Marmoset DC exhibited morphology similar to human DC, were capable of antigen uptake and presentation and had moderate allo-stimulatory ability. Monocyte-derived DC had a maturation-resistant immature phenotype, whereas haematopoietic precursor-derived DC were semi-mature in phenotype and function. This study confirms the feasibility of the marmoset as a unique small primate model in which to pursue DC-based immunotherapy strategies.

References

Nov 22, 1997·Journal of Immunological Methods·U O'DohertyM Pope
Jan 29, 2000·Scandinavian Journal of Immunology·J SöderlundP Biberfeld
May 29, 2000·Immunology Today·B A 't HartJ D Laman
Jan 10, 2002·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M G SoarsB Burchell
Mar 27, 2002·Nature Reviews. Immunology·Ken Shortman, Yong-Jun Liu
Dec 6, 2005·Journal of Immunological Methods·Lorenzo MortaraMichaela C Müller-Trutwin
Apr 14, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·L S KeanC P Larsen
Jun 13, 2006·Transplant International : Official Journal of the European Society for Organ Transplantation·Kenneth R McCurryAngus W Thomson
Jul 25, 2006·Journal of Immunological Methods·Shilpanjali PrasadPatrick Toby Hewlett Coates
Dec 16, 2006·Nature Reviews. Immunology·Ken Shortman, Shalin H Naik
Jul 14, 2007·Nature Reviews. Immunology·Adrian E Morelli, Angus W Thomson

❮ Previous
Next ❯

Citations

May 16, 2015·International Immunology·Shin ShimadaYoshie Kametani
Nov 30, 2011·Journal of Leukocyte Biology·Shilpanjali JesudasonP Toby H Coates
Aug 8, 2021·International Journal of Molecular Sciences·Mohammed Yusuf ZannaMd Isa Nur Mahiza

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cell Adhesion Molecules in the Brain

Cell adhesion molecules found on cell surface help cells bind with other cells or the extracellular matrix to maintain structure and function. Here is the latest research on their role in the brain.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.